Page 11 - Practice Guidelines News Today

'Use of biomarkers is no longer considered experimental and should be an integral part of IBD care and monitoring.'

/PRNewswire/ -- Today the Latin American and Caribbean Society of Medical Oncology (SLACOM) and National Comprehensive Cancer Network® (NCCN®) host the Latin...

Today the Latin American and Caribbean Society of Medical Oncology and National Comprehensive Cancer Network host the Latin American Regional Breast Cancer Summit: Advocating and Implementing Guideline-Concordant Cancer Care for Patients.

In crafting a patient-centered regimen, the convergence of expertise from physicians and pharmacists, paired with the values and preferences of patients, becomes paramount.

/PRNewswire/ -- Medical oncologist Lucio N. Gordan MD, president and managing physician of Florida Cancer Specialists & Research Institute, LLC (FCS), is lead...

/PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) today announced grants awarded for developing innovative...

Real-Time News, Market Data and Stock Quotes For Junior Mining Stocks.

Older treatments and novel options are changing the way obesity is treated and managed

TerSera Therapeutics LLC announced that The National Comprehensive Cancer Network Head and Neck Cancers Panel recommended the GnRH agonist goserelin for patients with recurrent, unresectable, or metastatic salivary gland tumors who were not eligible for surgery or radiation therapy.

Nicole Lamanna, MD, discusses treatment options for patients with chronic lymphocytic leukemia who develop resistance to a prior treatment.